Literature DB >> 3955519

Conservative treatment (chemotherapy/radiotherapy) of locally advanced breast cancer.

M Héry, M Namer, M Moro, J L Boublil, C M LaLanne.   

Abstract

Once treated almost exclusively by radical surgery, locally advanced breast cancers (Stages III, IV; MO) were later treated solely by irradiation, but local results (cosmesis and recurrences) remained poor. Since 1977, we have used induction chemotherapy in an attempt to treat subclinical metastatic disease while allowing better quality mammary conservation in a greater number of patients. From 1977 to 1980, 25 patients (Stages III, IV; MO) were treated by a sequential association of chemotherapy (Adriamycin [doxorubicin], vincristine, cyclophosphamide, 5-fluorouracil; 3 cycles) followed by irradiation (45 Gy to the breast and nodal areas; 15-30 Gy mammary boost dose). Responses of 50% or more were observed in 86% of the breast lesions and in 80% of nodal lesions. This sequential treatment was always well tolerated. Local recurrences occurred in six patients (24%) who underwent mastectomy without any complications. The survival rate at 4 years is 55%.

Entities:  

Mesh:

Year:  1986        PMID: 3955519     DOI: 10.1002/1097-0142(19860501)57:9<1744::aid-cncr2820570906>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Concomitant adjuvant chemotherapy and radiotherapy for high risk breast cancer patients.

Authors:  R Hansen; B Erickson; R Komaki; N Janjan; J Cox; J F Wilson; T Anderson
Journal:  Breast Cancer Res Treat       Date:  1991 Jan-Feb       Impact factor: 4.872

Review 2.  Management of locally advanced breast cancer.

Authors:  P I Borgen
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

3.  Neoadjuvant chemotherapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) or cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in 69 cases of locally advanced (stage IIIb) breast cancer.

Authors:  P Gupta; L Bijlani; G K Rath; A Misra; M C Mishra; N K Shukla; A Kriplani; B M Kapur
Journal:  Jpn J Surg       Date:  1991-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.